Piper Jaffray Sees Potential In UniQure NV And Bristol-Myers Squibb Collaboration

On Monday, uniQure NV and Bristol-Myers Squibb announced an exclusive strategic collaboration in which the agreement gives Bristol-Myers “exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases.”